Kindbody was founded in 2018 by Cynthia Hudson, Fahimeh Sasan, Gina Bartasi, and Joanne Schneider. Kindbody has not officially endorsed a plan to participate in an IPO.
Kindbody is a network of fertility clinics that offers both virtual and in-person care. Per Forge data, Kindbody has raised a total of $306.3 million in funding over 10 rounds. Their latest funding was raised on May 1, 2023. Key investors include Google Ventures, Perceptive Advisors, Morgan Health, RRE Ventures, and Claritas Health Ventures.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/01/2023 | Series D | $30MM | $xx.xx | $1.81B | Morgan Health, Perceptive Investors | |
Price per Share
$xx.xx
Shares Outstanding
582,329
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Morgan Health, Perceptive Investors
|
||||||
08/19/2022 | Series C-3 | $79.71MM | $xx.xx | $1.85B | What If Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,547,230
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
What If Ventures
|
||||||
02/08/2022 | Series C-2 | $30MM | $xx.xx | $1.19B | What If Ventures | |
Price per Share
$xx.xx
Shares Outstanding
834,725
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
What If Ventures
|
||||||
02/01/2022 | Series C-1 | $75MM | $xx.xx | $1.19B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,086,811
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
06/25/2021 | Series C | $61.89MM | $xx.xx | $670.48MM | Bramalea Partners, Claritas Health Ventures, Eldridge, Gv, Monashee Investment Management, Perceptive Advisors, Rock Springs Capital, Rre Ventures | |
Price per Share
$xx.xx
Shares Outstanding
2,815,304
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bramalea Partners, Claritas Health Ventures, Eldridge, Gv, Monashee Investment Management, Perceptive Advisors, Rock Springs Capital, Rre Ventures
|
||||||
07/08/2020 | Series B | $32MM | $xx.xx | $181.18MM | Claritas Health Ventures, Freemark Capital, Goodgrower, Gv, Nfp Ventures, Perceptive Advisors, Rock Springs Capital, Rre Ventures | |
Price per Share
$xx.xx
Shares Outstanding
5,449,590
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Claritas Health Ventures, Freemark Capital, Goodgrower, Gv, Nfp Ventures, Perceptive Advisors, Rock Springs Capital, Rre Ventures
|
||||||
04/17/2019 | Series A | $22.47MM | $xx.xx | $127.98MM | Green D Ventures, Perceptive Advisors, Rre Ventures, Trail Mix Ventures, Winklevoss Capital | |
Price per Share
$xx.xx
Shares Outstanding
4,273,488
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Green D Ventures, Perceptive Advisors, Rre Ventures, Trail Mix Ventures, Winklevoss Capital
|
||||||
01/01/2019 | Series Seed | $575,000.00 | $xx.xx | $56.23MM | Chelsea Clinton, Halle Tecco, Leandra Medine, Marc Mezvinsky, Marco Demeireles, Nat Turner, Tq Ventures, Vivek Garipalli | |
Price per Share
$xx.xx
Shares Outstanding
287,500
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chelsea Clinton, Halle Tecco, Leandra Medine, Marc Mezvinsky, Marco Demeireles, Nat Turner, Tq Ventures, Vivek Garipalli
|
||||||
01/01/2019 | Series Seed-2 | $4.2MM | $xx.xx | $56.23MM | Chelsea Clinton, Halle Tecco, Leandra Medine, Marc Mezvinsky, Marco Demeireles, Nat Turner, Tq Ventures, Vivek Garipalli | |
Price per Share
$xx.xx
Shares Outstanding
1,543,153
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chelsea Clinton, Halle Tecco, Leandra Medine, Marc Mezvinsky, Marco Demeireles, Nat Turner, Tq Ventures, Vivek Garipalli
|
||||||
06/30/2018 | Series Founder Convertible | $1.56MM | $xx.xx | $7.8MM | Annbeth Eschbach, Gina Bartasi | |
Price per Share
$xx.xx
Shares Outstanding
8,500,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Annbeth Eschbach, Gina Bartasi
|